New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic leukemia (CLL). A pair of studies examining the role of venetoclax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback